Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Viropro logo — company profile

Viropro

Founded 1982 Convertible Note Total: $500.00K Biotechnology, Manufacturing

General Information

Company Name Viropro
Founded Year 1982
Industries Biotechnology, Manufacturing
Funding Stage Convertible Note
Social

Get notified when Viropro moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Viropro

Viropro is a publicly traded company based in Nevada, founded in 1982. Specializing in the development of cell lines and biopharmaceutical processes, Viropro licenses these manufacturing processes to international partners for the production and distribution of the final products. The company is currently exploring partnerships for its biosimilar cell lines and manufacturing processes in the Biotechnology and Manufacturing industries. Viropro received a $500.00K Convertible Note investment on 25 August 2014. With its focus on innovative biopharmaceutical processes and an emphasis on international partnerships, Viropro presents an intriguing opportunity for potential venture capital investment.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• - 25 Aug 2014

Viropro Alternatives & Competitors

Viropro vs
ACYTE Biotech
ACYTE Biotech

ACYTE Biotech supplies proprietary mammalian cell lines and technologies to enhance cell engineering...

2 employees
Viropro vs
ExcellGene SA
ExcellGene SA Switzerland

We are a CDMO providing Swiss quality cell line development and protein expression services. Expect...

Unknown
66 employees
Biotechnology, Information Technology
Viropro vs
Cytosurge
Cytosurge Switzerland

FluidFM® for single-cell manipulation and CRISPR, turning genetic designs into cures, bridging desig...

42 employees
Information Technology

FAQ About Viropro

Viropro, a publicly traded company based in Nevada, specializes in the development of cell lines and biopharmaceutical processes. The company licenses these manufacturing processes to international partners for the production and distribution of the final products. Currently, Viropro is exploring pa...
Viropro was founded in 1982.
Viropro operates in the following industries: Biotechnology, Manufacturing.
Viropro has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Convertible Note.
Top alternatives and competitors to Viropro include ACYTE Biotech, ExcellGene SA, Cytosurge, Health & Biotech, Aurora Solar Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Viropro and ACYTE Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Viropro and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy